BOK Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.55K Buy
+48
New +$5.9K ﹤0.01% 1027
2025
Q3
Sell
-155
Closed -$19.3K 1189
2025
Q2
$19.3K Buy
155
+150
+3,000% +$19.1K ﹤0.01% 914
2025
Q1
$636 Hold
5
﹤0.01% 1207
2024
Q4
$774 Buy
5
+3
+150% +$430 ﹤0.01% 1218
2024
Q3
$278 Hold
2
﹤0.01% 1305
2024
Q2
$252 Hold
2
﹤0.01% 1148
2024
Q1
$366 Buy
2
+1
+100% +$190 ﹤0.01% 1129
2023
Q4
$179 Hold
1
﹤0.01% 1246
2023
Q3
$135 Sell
1
-168
-99% -$27.5K ﹤0.01% 1170
2023
Q2
$23.9K Sell
169
-82
-33% -$13.1K ﹤0.01% 858
2023
Q1
$42.3K Buy
+251
New +$44.8K ﹤0.01% 854
2022
Q2
Sell
-1,186
Closed -$223K 967
2022
Q1
$223K Sell
1,186
-116
-9% -$22K ﹤0.01% 900
2021
Q4
$345K Sell
1,302
-14
-1% -$3.77K 0.01% 787
2021
Q3
$380K Buy
+1,316
New +$338K 0.01% 764
2021
Q1
Sell
-1,203
Closed -$231K 942
2020
Q4
$231K Sell
1,203
-247
-17% -$44.9K ﹤0.01% 831
2020
Q3
$214K Buy
+1,450
New +$207K ﹤0.01% 790

Other funds holding RGEN

BOK Financial's RGEN Position: Q2 2026 in Review

BOK Financial opened a new position in Repligen (RGEN) in Q2 2026: 48 shares worth $6.55K. The stake represents ﹤0.01% of the portfolio and ranks #1027 among its holdings. This is a return to the name: BOK Financial previously reported a position in RGEN as recently as Q2 2025.

BOK Financial first reported a position in RGEN in Q3 2020 and has held it in 16 quarters since. The position peaked at $380K in Q3 2021. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • BOK Financial held 48 shares of Repligen worth $6.55K as of Q2 2026.
  • Repligen was a new BOK Financial position in Q2 2026.
  • Repligen made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #1027 holding.
  • BOK Financial first reported a position in Repligen in Q3 2020 and has held it in 16 quarters since.
  • BOK Financial's Repligen position peaked at $380K in Q3 2021.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.